☆Medicxi Ventures Management (Jersey) Ltd
Quality Q
0.000
AUM ($M)
177
Positions
3
Turnover
0.81
Top-10 wt
100%
Herfindahl
0.401
History (qtrs)
6
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 4 positions · portfolio value $177M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆PHAT funds › | PHATHOM PHARMACEUTICALS INC | HOLD | — | 45.6% | +37.2% | 81.0 | 7,464,572 | +0 | 0 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | TRIM | — | 42.2% | +33.5% | 74.9 | 2,208,639 | -465,543 | 0 | — |
| ☆AURA funds › | AURA BIOSCIENCES INC | HOLD | Common Stock | 12.2% | +10.1% | 21.6 | 3,039,892 | +0 | 0 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS PLC | EXIT | — | 0.0% | -80.8% | 0.0 | 0 | -19,963,157 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 177 | 3 | 0.81 | 100% | 0.401 | 0.000 | — | left |
| 2026Q1 | 982 | 4 | 0.21 | 100% | 0.667 | 0.828 | — | in |
| 2025Q4 | 835 | 5 | 0.06 | 100% | 0.407 | 0.927 | — | in |
| 2025Q3 | 744 | 5 | 0.13 | 100% | 0.459 | 0.864 | — | in |
| 2025Q2 | 427 | 5 | 0.12 | 100% | 0.425 | 0.857 | — | entered |
| 2025Q1 | 438 | 5 | 0.00 | 100% | 0.465 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status